Shanghai No1 Pharmacy Co Ltd (600833.SS) stock: key figures, P/E, revenue and dividend
Consumer Staples · Drug Retail · China · ISIN CNE000000412
Shanghai No1 Pharmacy Co Ltd financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.92 bn CNY | 2.13 bn CNY |
| Gross profit | 317.20 m CNY | 341.50 m CNY |
| Operating income | 208.07 m CNY | 8.51 m CNY |
| EBIT | 223.03 m CNY | 80.56 m CNY |
| Net income | 163.06 m CNY | 57.75 m CNY |
| Diluted EPS – continuing operations | 0.73 CNY | 0.26 CNY |
Full history since 1992, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shanghai No1 Pharmacy Co Ltd
Shanghai No.1 Pharmacy Co.,Ltd., together with its subsidiaries, engages in the retail and wholesale of pharmaceutical products in China. It sells food, medical equipment, health convenience products, and other commodities. The company serves medical institutions, pharmacies, commodity distribution companies, and franchise stores. Shanghai No. 1 Pharmacy Co.,Ltd. was founded in 1992 and is headquartered in Shanghai, China.
More stocks
- Hongli Group Inc. Ordinary Shares (HLP)
- Nantong Acetic Acid Chemical Co Ltd (603968.SS)
- Weihai Baihe Biology Technological Co. Ltd. (603102.SS)
- Fujian Nanwang Environment Protection Scien-Tech Co. Ltd. A (301355.SZ)
- Cantor Equity Partners VII, Inc. Class A Ordinary Shares (CAES)
- Kansas City Life Insurance Company (KCLI)
- Misun Technology Co Ltd (301577.SZ)
- Idaho Strategic Resources, Inc. (IDR)
- Samyang Cor (145990.KS)
- American Bitcoin Corp. (ABTC)
- Asia Metal Industries Inc (6727.TWO)
- Jiangsu Jinling Sports Equipment Co Ltd (300651.SZ)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.